课题基金 / 基金详情

Growth suppression of renal cell carcinoma cell lines by a dominant negative H-ras mutant

Growth suppression of renal cell carcinoma cell lines by a dominant negative H-ras mutant
显性失活 H-ras 突变体对肾细胞癌细胞系生长的抑制作用
批准号:
08671786
负责人:
SHINOHARA Nobuo
金额:
$1.34万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1997

项目摘要

项目成果

SHINOHARA Nobuo的其他基金

相似基金

相关文献

中文摘要
翻译
我们研究了N116Y是否可以抑制肾细胞癌(RCC)细胞系的生长,N116Y是通过酪氨酸取代天冬酰胺-116而从v-H-ras癌基因中衍生出来的。为了研究显性H-ras阴性突变体N116Y的高表达是否会影响肿瘤细胞的增殖,我们构建了一个高效的N116Y表达载体_pZIP-N116Y,并通过脂质转染程序转染了3个RCC细胞系(ACHN,NT-2, SMKT-R3)。转染_pZIP-N116Y完全抑制ACHN、NT-2、SMKT-R3的集落形成,G418选择后没有细胞存活。尽管_pZIP-N116Y可能是一种有效的RCC细胞抑制因子,但_pZIP-N116Y的抑制活性可能取决于neo基因的失活。为了排除这种可能性,我们以10:1和0:1的比例共转染含有_pZIP-N116Y和_pSV2_<neo>的质粒,检测了6株RCC细胞系(ACHN、NT-2、OSRC2、SMKTR-2、SMKTR-3、SMKTR-4)的集落形成能力。与对照转染(0∶1)相比,g418耐药菌落数分别为4% (ACHN)、6% (NT-2)、10% (OSRC2)、13%(SMKTR-2)、20% (SMKTR-3)和9% (SMKTR-4)。为了阐明N116Y对RCC细胞株生长抑制的作用机制,我们分析了介导Ras蛋白激活的so蛋白的表达。AII5 RCC细胞株(ACHN、NT-2、SMKT-R-3、SMKT-R-4、OS-RC-2)中Sos蛋白表达水平较高,而正常肾组织中Sos蛋白表达量极少。这些结果表明,显性负H-ras突变体N116Y可以抑制RCC细胞系的增殖。
英文摘要
We examined whether N116Y,which derived from the v-H-ras oncogene by substituting the asparagine-116 with tyrosine, can inhibit the growth of renal cell carcinoma (RCC) cell lines.In order to examine whether high expression of a dominant negative H-ras mutant, N116Y,affects tumor cell proliferation, we constructed an efficient N116Y expression vector, _pZIP-N116Y,and transfected three RCC cell lines (ACHN,NT-2, SMKT-R3) by the lipofection procedure. Transfection of _pZIP-N116Y completely inhibited the colony formation of ACHN,NT-2, SMKT-R3 and no cell survived after G418 selection. Although _pZIP-N116Y may be a potent suppressor of RCC cells, it is possible that the suppressor activity of _pZIP-N116Y depends on neo gene inactivation. To exclude this possibility, we examined the colony forming ability of 6 RCC cell lines (ACHN,NT-2, OSRC2, SMKTR-2, SMKTR-3, SMKTR-4) containing both _pZIP-N116Y and _pSV2_<neo> by cotransfection of these plasmids at the rates of 10 : 1 and 0 : 1. The numbers of G418-resistant colonies were 4% (ACHN), 6% (NT-2) , 10% (OSRC2) , 13%(SMKTR-2) , 20% (SMKTR-3) , and 9% (SMKTR-4) in comparison with the control transfection (0 : 1).To clarify the mechanism of growth suppression in RCC cell lines by N116Y,we analyzed the expression of son of sevenless (Sos) protein which mediates the the activation of Ras protein . AII5 RCC cell lines (ACHN,NT-2, SMKT-R-3, SMKT-R-4, OS-RC-2) expressed compartively high levels of Sos protein, while the amount of Sos protein was very small in normal kidney tissues.These results suggest that a dominant negative H-ras mutant, N116Y,can suppress the proliferation of RCC cell lines.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Shinohara, N.et al: "The significance of ras guanine nucleotide exchange factor, son of sevenless protein, in renal cell carcinoma cell lines." Journal of Urology. 158(3). 908-911 (1997)
Shinohara, N. 等人:“七少蛋白之子 ras 鸟嘌呤核苷酸交换因子在肾细胞癌细胞系中的意义。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Shinohara,N.et.al.: "The significance of ras guanine nucleotide exchange factor,son of sevenless protein,in renal cell carcinoma cell lines." Journal of Urology. 158(3). 908-911 (1997)
Shinohara, N.et.al.:“七少蛋白之子 ras 鸟嘌呤核苷酸交换因子在肾细胞癌细胞系中的意义。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
7
    Discovery of diagonositc and therapeutic biomarker by circulating tumor endothelial cells in metastatic renal cell carcinoma
    • 批准号:
      23592320
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.16万
    • 财政年份:
      2011
    • 负责人:
      SHINOHARA Nobuo
    • 依托单位:
    Development of new screening system for anti-angiogenic drugs using tumor associated endothelial cells derived from renal cell carcinoma
    • 批准号:
      20591847
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2008
    • 负责人:
      SHINOHARA Nobuo
    • 依托单位:
    Analysis of expression pattern of the gene which is related to the radiation sensitivity in urothelial cancer and its clinical application
    • 批准号:
      15390482
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $5.12万
    • 财政年份:
      2003
    • 负责人:
      SHINOHARA Nobuo
    • 依托单位:
    Establishment of gene therapy against bladder cancer utilizing gelsolin gene and a dominant negative ras mutant
    • 批准号:
      12470326
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $4.03万
    • 财政年份:
      2000
    • 负责人:
      SHINOHARA Nobuo
    • 依托单位:
    海外基金